Corrigendum: A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

Research output

Research output per year 2016 2016 2016

• 7 Citations
• 1 Article

Research output per year

Research output per year

Search results

• 2016

  A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

  Tosco, A., De Gregorio, F., Esposito, S., De Stefano, D., Sana, I., Ferrari, E., Sepe, A., Salvadori, L., Buonpensiero, P., Di Pasqua, A., Grassia, R., Leone, C. A., Guido, S., De Rosa, G., Lusa, S., Bona, G., Stoll, G., Maiuri, M. C., Mehta, A., Kroemer, G., & 2 othersMaiuri, L. & Raia, V., 1 Apr 2016, In: Cell Death & Differentiation. 23, 8, p. 1380-1393 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cysteamine 100%
  • epigallocatechin gallate 88%
  • Cystic Fibrosis Transmembrane Conductance Regulator 87%
  • Cystic Fibrosis 67%
  • Autophagy 66%
  78 Citations (Scopus)

  199 Downloads (Pure)